Sector: Health Care
Director information for LEXEO THERAPEUTICS INC
Board as disclosed in the proxy statement filed April 30, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Brenda Cooperstone, M.D. | Class III Director | 61 | [] | [] | 2026 |
| Laura Sepp-Lorenzino, Ph.D. | Class II Director | 65 | [] | [] | 2026 |
| Mette Kirstine Agger | Class I Director | 61 | [] | [] | 2026 |
| Paula HJ Cholmondeley | Class III Director | 78 | [] | [] | 2026 |
| Reinaldo Diaz | Class II Director | 72 | [] | [] | 2026 |
| R. Nolan Townsend | Chief Executive Officer and Class III Director | 46 | [] | [] | 2026 |
| Steven Altschuler, M.D. | Chairman of the Board of Directors and Class II Director | 72 | [] | [] | 2026 |
| Tim Van Hauwermeiren | Class I Director | 54 | [] | [] | 2026 |
| Tolga Tanguler | Class I Director | 53 | [] | [] | 2026 |
